Valeant profit, revenue fall short of expectations; reaffirms 2016 guidance
Valeant Pharmaceuticals reported quarterly earnings and revenue that fell short of analysts' expectations on Tuesday.
Valeant Pharmaceuticals reported quarterly earnings and revenue that fell short of analysts' expectations on Tuesday.